News about TOV and NYU’s commercialization successes.
NYU Technology Opportunities & Ventures (TOV), the innovation management office serving NYU Langone Health and New York University, has developed GooseFarmAI, …
Ajax Therapeutics, a biotechnology company co-founded by experts in JAK biology and structures from leading research institutions, including NYU Langone …
June 5, 2026 – NYU Langone Health recently hosted AstraZeneca for an oncology-focused industry day designed to deepen collaboration across …
TOV is excited to announce the launch of Mobile Defender, a new NYU hardware and software automotive cybersecurity startup focused …
NYU Langone Health held its second annual Innovators’ Dinner on Wednesday, March 11, celebrating and promoting the commercialization of innovative …
On Thursday, January 29, Technology Opportunities & Ventures (TOV) launched SciCafé @ NYU Langone Health, an invitation-only forum designed to …
NYU Langone Health has appointed Dr. Kevin Sampson to the newly created role of Director of Corporate Engagement within Technology …
Gloria Coruzzi, PhD, Carroll & Milton Petrie Professor at New York University’s College of Arts and Science, has been named …
NYU Langone’s chief scientific officer, Dafna Bar-Sagi, PhD, has been named to the National Academy of Inventors (NAI) for pioneering discoveries …
